PH
Photocure ASA
PHCUF · OTC
$5.65 -5.99% (-$0.36)
Market Cap 1.48B kr
P/E Ratio 18.83x
Div. Yield -
ROE 14.63%
Bulios Fair Price
$6.9
22.1% upside
Current Price
$5.65
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PHCUF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
80 /100
Cheap EV/EBITDA 5.86x
P/S 2.19x
P/B 2.44x
Growth
61 /100
Stable Book val. growth 1.51%
Rev. growth 10.63%
FCF growth N/A
Profitability
88 /100
Strong Net margin 11.63%
Op. margin 31.18%
FCF margin 12.99%
Quality
82 /100
Excellent ROE 14.63%
ROA 8.73%
Asset turnover 0.75x
Debt
91 /100
Low Current ratio 3.65x
Int. coverage 4.84x
Net debt/EBITDA -0.67x
Stability
33 /100
Unstable Rev. volatility 14.10%
EPS volatility 394.87%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PHCUF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Daniel Schneider
Employees
101
Headquarters
Oslo
Upcoming events
28 OCT
Earnings
Upcoming earnings report